Lisata Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.75 | -$0.75 | -$0.75 |
| Q2 2024 | 1 | -$0.75 | -$0.75 | -$0.75 |
| Q3 2024 | 2 | -$0.95 | -$0.73 | -$0.85 |
| Q1 2025 | 1 | -$0.74 | -$0.74 | -$0.74 |
| Q2 2025 | 1 | -$0.61 | -$0.61 | -$0.61 |
| Q3 2025 | 1 | -$0.78 | -$0.78 | -$0.78 |
| Q4 2025 | 1 | -$0.75 | -$0.75 | -$0.75 |
Lisata Therapeutics, Inc. Earnings Date And Information
Lisata Therapeutics, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.61 earnings per share for the quarter, topping analysts' consensus estimates of $-0.75 by $0.14. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Lisata Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-2.58 diluted earnings per share) and currently has a price-to-earnings ratio of -1.09. Lisata Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Lisata Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.59 | $0 | $0 | ||
| 08/12/2024 | Q2 2024 | -$0.75 | -$0.61 | 0.14 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.73 | -$0.65 | 0.08 | $0 | |
| 12/30/2023 | Q4 2023 | -$0.66 | $0 | |||
| 11/02/2023 | Q3 2023 | -$0.93 | -$0.65 | 0.28 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.70 | -$0.50 | 0.2 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.81 | -$0.61 | 0.2 | $0 | |
| 03/30/2023 | Q4 2022 | -$0.45 | $121.37 M | |||
| 11/10/2022 | Q3 2022 | -$0.90 | -$7.73 | -6.83 | $0 | |
| 06/30/2022 | Q2 2022 | -$1.60 | $0 | |||
| 03/31/2022 | Q1 2022 | -$1.05 | $0 | |||
| 12/31/2021 | Q4 2021 | -$1.70 | $0 | |||
| 09/30/2021 | Q3 2021 | -$1.74 | $0 | |||
| 06/30/2021 | Q2 2021 | -$1.43 | $0 | |||
| 03/31/2021 | Q1 2021 | -$2.87 | $0 | |||
| 12/31/2020 | Q4 2020 | -$0.29 | $0 | |||
| 09/30/2020 | Q3 2020 | -$4.30 | $0 | |||
| 06/30/2020 | Q2 2020 | $7.50 | $0 | |||
| 03/31/2020 | Q1 2020 | -$5.63 | $0 | |||
| 12/31/2019 | Q4 2019 | -$0.47 | $0 |
Lisata Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Lisata Therapeutics, Inc.'s earnings date?
Lisata Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
Did Lisata Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Lisata Therapeutics, Inc. (:LSTA) reported $-0.61 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.75 by $0.14.
-
How can I listen to Lisata Therapeutics, Inc.'s earnings conference call?
The conference call for Lisata Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Lisata Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Lisata Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Lisata Therapeutics, Inc. generate each year?
Lisata Therapeutics, Inc. (:LSTA) has a recorded net income of $0. Lisata Therapeutics, Inc. has generated $-2.58 earnings per share over the last four quarters.
-
What is Lisata Therapeutics, Inc.'s price-to-earnings ratio?
Lisata Therapeutics, Inc. (:LSTA) has a price-to-earnings ratio of -1.09 and price/earnings-to-growth ratio is -0.47.
